Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C X Li

Showing results (171-180 of 174) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 174 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2023
[Efficacy and safefy of Polymyxin B treatment for neutropenic patients suffering from refractory Gram-negative bacterial bloodstream infection]M Zhou, H Z Kang, C Y Gu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|March 9, 2025
[Surgical treatment and survival analyses of intrahepatic cholangiocarcinoma]H Zhang, C Y Jiao, C X Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[An experimental study of CD4 targeted chimeric antigen receptor modified T cell with anti-lymphoma activity]G H Chen, H W Huang, Y Wang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|March 3, 2024
[Surgical treatment and prognosis analysis of hilar cholangiocarcinoma]X C Li, C X Li, H Zhang, et al.
Pageof 18

Showing results (171-180 of 174) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 174 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 7, 2023
[Efficacy and safefy of Polymyxin B treatment for neutropenic patients suffering from refractory Gram-negative bacterial bloodstream infection]M Zhou, H Z Kang, C Y Gu, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|March 9, 2025
[Surgical treatment and survival analyses of intrahepatic cholangiocarcinoma]H Zhang, C Y Jiao, C X Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|March 22, 2018
[An experimental study of CD4 targeted chimeric antigen receptor modified T cell with anti-lymphoma activity]G H Chen, H W Huang, Y Wang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|March 3, 2024
[Surgical treatment and prognosis analysis of hilar cholangiocarcinoma]X C Li, C X Li, H Zhang, et al.
Pageof 18